Alpha Tau Medical up sharply as brain cancer trial begins
The company's share price rose 21% on Nasdaq last week. The share price of Israeli cancer treatment company Alpha Tau Medical (Nasdaq: DRTS) rose by 21% last week, following the start of a clinical trial of its technology in the treatment of brain …